You have 9 free searches left this month | for more free features.

Selective Serotonin Reuptake Inhibitor

Showing 51 - 75 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Therapeutic Mechanism of Antidepressants for Refractory FD Trial in Hangzhou (selective serotonin reuptake inhibitor (SSRI) or

Unknown status
  • Therapeutic Mechanism of Antidepressants for Refractory FD
  • selective serotonin reuptake inhibitor (SSRI) or serotonin noradrenaline reuptake inhibitor (SNRI) antidepressants
  • conventional therapy
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 2, 2019

Stress Urinary Incontinence, Fecal Incontinence Trial in Copenhagen (Citalopram 40mg, Reboxetine 8 mg, Placebo oral tablet)

Completed
  • Stress Urinary Incontinence
  • Fecal Incontinence
  • Citalopram 40mg
  • +2 more
  • Copenhagen, Denmark
    Department of Clinical Pharmacology, Bispebjerg and Frederiksber
Jun 8, 2021

MDDs Trial in Tianjin (N-acetylcysteine, comparator of N-acetylcysteine)

Recruiting
  • Major Depressive Disorders
  • Tianjin, Tianjin, China
    Tianjin Anding Hospital
Sep 21, 2022

Depressive Disorder Trial in Tanta (Fluoxetine 20 mg, Dapagliflozin 10mg Tab, Atorvastatin 80mg)

Not yet recruiting
  • Depressive Disorder
  • Fluoxetine 20 mg
  • +2 more
  • Tanta, Shebeen El-Kom, Egypt
    Faculty of Medicine, Menoufia University
Mar 19, 2023

Nocturnal Enuresis Trial in Mansoura (Fluoxetine, Placebo)

Unknown status
  • Nocturnal Enuresis
  • Mansoura, Dakahlia, Egypt
    Mansoura urology and nephrology center
Dec 15, 2020

Success of Inferior Alveolar Nerve Block in Women Taking

Completed
  • Local Anesthesia
  • selective serotonin reuptake inhibitor
  • Isfahan, Iran, Islamic Republic of
    School of Dentistry, Isfahan University of Medical Sciences
Feb 11, 2019

MDD Trial in Erbil (Citalopram (tablet) 20 mg + Pentoxifylline (tablet) 400Mg, Citalopram (tablet) 20 mg + Placebo (tablet))

Completed
  • Major Depressive Disorder
  • Citalopram (tablet) 20 mg + Pentoxifylline (tablet) 400Mg
  • Citalopram (tablet) 20 mg + Placebo (tablet)
  • Erbil, Iraq
    Hawler Psychiatric Hospital and Private Clinic
Mar 16, 2022

Depression Trial in Winston-Salem (Fluoxetine 20 MG, Duloxetine 30 MG, Observation)

Not yet recruiting
  • Depression
  • Fluoxetine 20 MG
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 28, 2023

Tamoxifen in Breast Cancer and in Women at High-Risk of Breast

Active, not recruiting
  • Breast Cancer
  • +3 more
  • citalopram hydrobromide
  • +10 more
  • Indianapolis, Indiana
  • +3 more
Feb 18, 2022

PTSD Trial in Boston (LDAEP, Placebo, sertraline)

Recruiting
  • Posttraumatic Stress Disorder
  • LDAEP
  • +2 more
  • Boston, Massachusetts
    VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Mar 9, 2022

Healthy Young and Older Adults Trial in Berlin (procedure, drug, other)

Completed
  • Healthy Young and Older Adults
  • tDCS
  • +2 more
  • Berlin, Germany
    Charite Universitätsmedizin Berlin
May 10, 2021

Depression, Depressive Disorder Trial in Bhopal (Healthy Activity Program (HAP), Antidepressant medication (ADM))

Recruiting
  • Depression
  • Depressive Disorder
  • Healthy Activity Program (HAP)
  • Antidepressant medication (ADM)
  • Bhopal, Madhya Pradesh, India
    Sangath
Nov 22, 2023

Acute Stroke, Visual Field Loss Trial in Rochester (Fluoxetine, Placebo)

Terminated
  • Acute Stroke
  • Visual Field Loss
  • Rochester, New York
    Strong Memorial Hospital
Sep 16, 2021

Sexual Dysfunction Trial in Newport Beach (Viveve System)

Unknown status
  • Sexual Dysfunction
  • Viveve System
  • Newport Beach, California
    Southern California Center for Sexual Health and Survivorship Me
Nov 19, 2018

MDD Trial in Taichung (NMDAE, Sertraline, Placebo Cap)

Recruiting
  • Major Depressive Disorder
  • Taichung, Taiwan
    Department of Psychiatry, China Medical University Hospital
Nov 16, 2021

OCD, EEG With Periodic Abnormalities Trial in Istanbul (Deep Transcranial Magnetic Stimulation, Paroxetine)

Active, not recruiting
  • Obsessive-Compulsive Disorder
  • EEG With Periodic Abnormalities
  • Istanbul, Beykoz, Turkey
    Istanbul Medipol University
Dec 26, 2021

Hospital Mobility, Mobility Limitation, Life-Space Trial in Villars-sur-Glâne, Bern (INTOMOB intervention)

Recruiting
  • Hospital Mobility
  • +7 more
  • INTOMOB intervention
  • Villars-sur-Glâne, Fribourg, Switzerland
  • +2 more
Dec 19, 2022

Dyspepsia, Anxiety, Depression Trial in Hong Kong (Escitalopram, Placebo)

Completed
  • Dyspepsia
  • +2 more
  • Hong Kong, Hong Kong
    Prince of Wales Hospital
Jan 30, 2019

MDD Trial in Dhaka (SSRI with Zinc Sulfate)

Completed
  • MDD
  • SSRI with Zinc Sulfate
  • Dhaka, Bangladesh
    BSMMU
Jan 26, 2021

OCD Trial in Hamilton (SSRIs)

Completed
  • Obsessive-Compulsive Disorder
  • Hamilton, Ontario, Canada
    MacAnxiety Research Centre
Aug 31, 2020

Parkinson Disease Trial in Ann Arbor (Citalopram 20mg, Placebo)

Recruiting
  • Parkinson Disease
  • Citalopram 20mg
  • Placebo
  • Ann Arbor, Michigan
    University of Michigan
Mar 30, 2022

Depression, Unipolar, PTSD, Trauma Trial in Kisumu (Fluoxetine, Interpersonal Psychotherapy)

Active, not recruiting
  • Depression, Unipolar
  • +2 more
  • Kisumu, Kenya
  • +2 more
Oct 31, 2022

Anxiety, Separation, Anxiety, Generalized, Anxiety, Social Trial in Los Angeles, Chicago, Cincinnati (Cognitive Behavioral

Recruiting
  • Anxiety, Separation
  • +2 more
  • Cognitive Behavioral Therapy (CBT)
  • Combination therapy (COMB)
  • Los Angeles, California
  • +2 more
Sep 1, 2021

MDD Trial in Shanghai (SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors),

Not yet recruiting
  • Major Depressive Disorder
  • SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors)
  • +2 more
  • Shanghai, Shanghai, China
  • +3 more
Aug 24, 2020

Uremic Pruritis Trial in Alexandria (sertraline, )

Completed
  • Uremic Pruritis
  • Alexandria, Egypt
    Faculty of Medicine, Aexandria University
Dec 12, 2022